MAM
NVAX icon

Martingale Asset Management’s Novavax NVAX Stock Holding History

Martingale Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$806K Sell
85,571
-9,086
-10% -$81.4K 0.02% 575
2026
Q1 		$771K Sell
94,657
-100
-0.1% -$906 0.02% 558
2025
Q4 		$637K Buy
94,757
+105
+0.1% +$792 0.02% 558
2025
Q3 		$821K Buy
94,652
+6,791
+8% +$52.9K 0.02% 532
2025
Q2 		$554K Buy
87,861
+52,452
+148% +$347K 0.01% 601
2025
Q1 		$227K Sell
35,409
-3,700
-9% -$30.6K 0.01% 726
2024
Q4 		$314K Buy
39,109
+4,123
+12% +$39.7K 0.01% 683
2024
Q3 		$442K Sell
34,986
-1,898
-5% -$24.5K 0.01% 648
2024
Q2 		$467K Sell
36,884
-21,759
-37% -$219K 0.01% 611
2024
Q1 		$280K Buy
58,643
+18
+0% +$83 0.01% 716
2023
Q4 		$281K Buy
58,625
+13,218
+29% +$80.9K 0.01% 715
2023
Q3 		$329K Buy
45,407
+15,828
+54% +$126K 0.01% 674
2023
Q2 		$220K Buy
+29,579
New +$233K ﹤0.01% 750
2021
Q2 		– Sell
-7,612
Closed -$1.38M – 880
2021
Q1 		$1.38M Sell
7,612
-1,001
-12% -$199K 0.02% 345
2020
Q4 		$961K Sell
8,613
-300
-3% -$31.9K 0.01% 454
2020
Q3 		$966K Sell
8,913
-100
-1% -$12.2K 0.01% 647
2020
Q2 		$752K Buy
+9,013
New +$345K 0.01% 801

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Martingale Asset Management's NVAX Position: Q2 2026 in Review

Martingale Asset Management reduced its Novavax (NVAX) stake by 9.6% in Q2 2026, selling an estimated $81.4K and leaving 85,571 shares worth $806K. The position accounts for 0.02% of the portfolio, ranked #575.

Martingale Asset Management first reported a position in NVAX in Q2 2020 and has held it in 17 quarters since. The position peaked at $1.38M in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Martingale Asset Management held 85,571 shares of Novavax worth $806K as of Q2 2026.
  • Martingale Asset Management sold 9,086 Novavax shares in Q2 2026, an estimated $81.4K.
  • Novavax made up 0.02% of Martingale Asset Management's portfolio in Q2 2026, its #575 holding.
  • Martingale Asset Management first reported a position in Novavax in Q2 2020 and has held it in 17 quarters since.
  • Martingale Asset Management's Novavax position peaked at $1.38M in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.